ORPP logo

Osteoblasts : (Record no. 60943)

MARC details
000 -LEADER
fixed length control field 05676nam a22004573i 4500
001 - CONTROL NUMBER
control field EBC3020631
003 - CONTROL NUMBER IDENTIFIER
control field MiAaPQ
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729124139.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240724s2013 xx o ||||0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781624178078
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781624178061
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC3020631
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL3020631
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10678036
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)846919531
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC931.O73.O88 2013
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Scheurer, Hugo.
245 10 - TITLE STATEMENT
Title Osteoblasts :
Remainder of title Morphology, Functions and Clinical Implications.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Hauppauge :
Name of producer, publisher, distributor, manufacturer Nova Science Publishers, Incorporated,
Date of production, publication, distribution, manufacture, or copyright notice 2013.
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice ©2013.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (155 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Cell Biology Research Progress
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Intro -- OSTEOBLASTS -- OSTEOBLASTS -- Contents -- Preface -- Osteoblasts under Mechanical Strain -- Abstract -- Abbreviations -- 1. Introduction -- 1.1. Bone Tissue Cellular Structure -- 1.2. Osteoblasts -- 1.2.1. Osteoblast Origin and Life Cycle -- 1.2.2. Osteoblast Function -- 1.2.3. Growth Factor and Hormone Effects on Osteoblasts -- 1.3. Runx2 Transcription Factor in Bone Biology -- 1.3.1. Runx2 in Osteoblast Differentiation -- 1.3.2. Structure of Runx2 Gene -- 1.3.3. Runx2 Expression -- 2. Bone Remodeling -- 2.1. Regulation of Bone Remodeling -- 2.2. The Role of the RANK / RANKL / OPG System in Bone Remodeling -- 2.3. Bone Remodeling Pathophysiology -- 3. Mechanotransduction -- 3.1. Bone Remodeling and Mechanotransduction -- 3.2. Runx2 in Mechanotransduction -- 3.3. Nuclear Factor Κappa B (NF-κΒ) Transcription Factor in Mechanotransduction -- 3.4. Polycystins in Mechanotransduction -- 3.5. Model Systems for the Study of Mechanotransduction in Osteoblasts -- 3.6. The Role of Mechanotransduction in Bone Disease -- 3.7. Mechanical Stimulation as a Therapeutic Strategy against Bone Disease -- Conclusion -- References -- From Stem Cells to Osteoblast: Therapeutic Potential for Bone Tissue Engineering -- Abstract -- Introduction -- Mesenchymal Stem Cells -- Differentiation of MSC into Osteoblast -- Role of Growth Factors and Transcription Factors in Osteoblast Differentiation -- Role of Transcription Factor in Differentiation of Osteoblast -- Scaffolds -- Natural Scaffolds: Extracellular Matrix -- Glycosaminoglycans (GAGs) -- Chitosan Scaffold -- Tripolymer Scaffolds -- References -- Osteoblast Functions and their Role in Skeletal Bone Diseases -- Abstract -- Introduction -- Osteoblast Lineage and Differentiation -- Transcription Factors, Signaling Proteins and Osteoblast Differentiation -- Osteoblast Migration -- Osteoblasts and Bone Diseases.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Osteoporosis -- Osteoarthritis -- Osteogenesis Imperfecta -- Van Buchem Disease and Sclerosteosis -- Oculodentodigital Dysplasia -- Camurati-Engelmann Disease -- Cleidocranial Dysplaysia -- Osteoblastic Bone Metastasis -- Acknowledgment -- References -- Osteoblast Differentiation and Related Diseases -- Abstract -- Introduction -- A. Transcription Factors Regulating Osteoblast Differentiation -- RUNX2 -- TWIST1 -- MSX1 and MSX2 -- SP7/Osterix -- β-Catenin -- ATF4 -- FoxO1 -- B. Diseases Associated with Osteogenic Transcription Factors -- Cleidocranial Dysplasia (CCD) -- Saethre Chotzen Syndrome (SCS) -- Boston-Type Craniosynostosis -- Non-Collagenous Osteogenesis Imperfecta Caused by SP7/OSX Mutation -- Coffin-Lowry Syndrome (CLS) -- Neurofibromatosis Type I -- Conclusion -- References -- BMP and Osteoblastogenesis Inhibitors -- Abstract -- Bone Morphogenetic Proteins -- BMP-Smad Signaling -- Extracellular Inhibitor -- Cytomembrane Inhibitors -- Intracellular Inhibitors -- Nuclear Inhibitors, Which Interact with Runx2 or Osx -- MicroRNAs -- Prospect for Future Therapy -- References -- The Effect of Molecular and Biochemical Differentiation Agentson Bone Formation -- Abstract -- Introduction -- Osteoblast Differentiation and Inducer Materials -- Standard Medium for Osteogenic Cultures -- Medium Supplements -- Ascorbic Acid -- 1. The Effect of Ascorobic Acid on Osteoclast Formation -- 2.The Effect of Ascorbic Acid on Osteoblast Formation -- B-Glycerophosphate (BGP) -- Dexamethasone (Dex) -- Vitamin D3 -- Bone Morphogenic Protein 2(BMP-2) -- Collagen I and Vetronectin -- Conclusion and Further Remarks -- References -- Evaluation of Characteristics of Osteoblasts and Factors Relatedto Osteoblastic Differentiation and Mineralization -- Abstract -- Introduction -- Characteristics of Osteblast -- Bone Morphogenetic Protein (BMP) -- Various Agents.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Laboratory Experiments -- (1) Cellular Proliferation -- (2) Alkaline Phosphatase Activity Assays (ALP) -- (3) Mineralization Assay -- Conclusion -- References -- Index.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on publisher supplied metadata and other sources.
590 ## - LOCAL NOTE (RLIN)
Local note Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Osteoporosis.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Main entry heading Scheurer, Hugo
Title Osteoblasts: Morphology, Functions and Clinical Implications
Place, publisher, and date of publication Hauppauge : Nova Science Publishers, Incorporated,c2013
International Standard Book Number 9781624178061
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN)
Corporate name or jurisdiction name as entry element ProQuest (Firm)
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Cell Biology Research Progress
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3020631">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3020631</a>
Public note Click to View

No items available.

© 2024 Resource Centre. All rights reserved.